Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe

PURPOSE: This post‐authorisation safety study estimated the risk of anaphylaxis in patients receiving intravenous (IV) iron in Europe, with interest in iron dextran and iron non‐dextrans. Studies conducted in the United States have reported risk of anaphylaxis to IV iron ranging from 2.0 to 6.8 per...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortuny, Joan, von Gersdorff, Gero, Lassalle, Régis, Linder, Marie, Overbeek, Jetty, Reinold, Jonas, Toft, Gunnar, Timmer, Antje, Dress, Jochen, Blin, Patrick, Droz‐Perroteau, Cécile, Ehrenstein, Vera, Franzoni, Carla, Herings, Ron, Kollhorst, Bianca, Moore, Nicholas, Odsbu, Ingvild, Perez‐Gutthann, Susana, Schink, Tania, Rascher, Katherine, Rasouliyan, Lawrence, Rothman, Kenneth J., Saigi‐Morgui, Nuria, Schaller, Mathias, Smits, Elisabeth, Forstner, Michael, Bénichou, Jacques, Bircher, Andreas J., Garbe, Edeltraut, Rampton, David S., Gutierrez, Lia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457074/
https://www.ncbi.nlm.nih.gov/pubmed/34181291
http://dx.doi.org/10.1002/pds.5319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457074/
https://www.ncbi.nlm.nih.gov/pubmed/34181291
http://dx.doi.org/10.1002/pds.5319

Ejemplares similares